Case Report
Volume 3 Issue 4 - 2020
Pityriasis Rubra Pilaris in a 2-Year-Old Arabic Male; Case Report
Radwan Abotaleb, Mazen Elyahia and Iqbal Bukhari*
Dermatology Department, College of Medicine, Imam Abdulrahman Bin Faisal University and King Fahd Hospital of the University, Dammam, Saudi Arabia
*Corresponding Author: Iqbal Bukhari, Dermatology Department, College of Medicine, Imam Abdulrahman Bin Faisal University and King Fahd Hospital of the University, Dammam, Saudi Arabia.
Received: March 16, 2020; Published: March 31, 2020


Pityriasis rubra pilaris (PRP) is a skin disorder presenting with palmoplantar keratoderma and follicular hyperkeratotic papules that coalesce into large, scaly, erythematous plaques which may progress to exfoliative erythroderma. The exact incidence and pathogenesis are unknown. The diagnosis of PRP is based on the clinical signs and histopathological features mainly. Here we report the 23rd case of Pityriasis Rubra Pilaris type III reported in the medical literature.

Keywords: Pityriasis Rubra Pilaris; Erythroderma; Psoriasis; Keratosis Pilaris


  1. Gelmetti C., et al. “Pityriasis rubra pilaris in childhood: a long-term study of 29 cases”. Pediatric Dermatology 3 (1986): 446-451.
  2. Dingyuan Wang., et al. “Review on Pityriasis Rubra Pilaris”. American Journal of Clinical Dermatology 19 (2018): 377-390.
  3. Miralles ES., et al. “Pityriasis rubra pilaris and human immunodeficiency virus infection”. British Journal of Dermatology 133 (1995): 990-993.
  4. Klein A., et al. “Pityriasis rubra pilaris: a review of diagnosis and treatment”. American Journal of Clinical Dermatology 11 (2010): 157-170.
  5. Conaghan PG., et al. “The relationship between pityriasis rubra pilaris and inflammatory arthritis: case report and response of the arthritis to anti-tumor necrosis factor immunotherapy”. Arthritis and Rheumatology 42 (1999): 1998-2001.
  6. Wood GS and Reizner GT. “Other papulosquamous disorders”. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. Philadelphia: Elsevier Ltd (Saunders) (2012).
  7. Allison DS., et al. “Pityriasis rubra pilaris in children”. Journal of the American Academy of Dermatology 3 (2002): 386-389.
  8. Tholke A., et al. “Acute juvenile pityriasis rubra pilaris in a 2 year-old child”. Journal der Deutschen Dermatologischen Gesellschaft 2 (2004): 357-359.
  9. Stacey S., et al. “Pityriasis Rubra Pilaris in a 3-Year-Old Male”. Military Medicine3 (2016):e298-e301.
  10. Al-Natour S. “Pityriasis rubra pilaris: Report of 16 cases in Saudi Arabia”. Journal of the American Academy of Dermatology 62 (2010): AB130.
  11. Gonza´lez-Lo´pez A., et al. “HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy”. British Journal of Dermatology 140 (1999): 931-934.
  12. Martin AG., et al. “Pityriasis rubra pilaris in the setting of HIV infection: clinical behavior and association with explosive cystic acne”. British Journal of Dermatology 126 (1992): 617-620.
  13. Blasdale C., et al. “Spontaneous clinical improvement in HIV-associated follicular syndrome”. Clinical and Experimental Dermatology 29 (2004): 480-482.
  14. Fuchs-Telem D., et al. “Familial pityriasis rubra pilaris is caused by mutations in CARD14”. American Journal of Human Genetics 91 (2012): 163-170.
  15. Vanderhooft SL., et al. “Familial pityriasis rubra pilaris”. Archives of Dermatological 131 (1995): 448-453.
  16. Vasher M., et al. “Familial pityriasis rubra pilaris: report of a family and therapeutic response to etanercept”. Journal of Drugs in Dermatology 9 (2010): 844-850.
  17. Frazier CN and Ch’uan-K’uei H. “Cutaneous lesions associated with a deficiency in vitamin A in man”. Archives of Internal Medicine 48 (1931): 507-514.
  18. Frazier CN and Ch’uan-K’uei H. “Nature and distribution according to age of cutaneous manifestations of vitamin A deficiency: a study of two hundred and seven cases”. Arch Dermatol Syphilol 33 (1936): 825-852.
  19. Loewenthal LJA. “A new cutaneous manifestation in the syndrome of vitamin A deficiency”. Arch Dermatol Syphilol 28 (1933): 700-708.
  20. Stoll DM., et al. “Serum levels of retinol binding protein in patients with pityriasis rubra pilaris”. British Journal of Dermatology 108 (1983): 375.
  21. Yamamoto T and Yokoyama A. “Lymphocyte response to superantigen in a patient with childhood-onset pityriasis rubra pilaris”. International Journal of Dermatology 38 (1999): 639-640.
  22. Betlloch I., et al. “Acute juvenile pityriasis rubra pilaris: a superantigen mediated disease?” Pediatric Dermatology 18 (2001): 411-414.
  23. Kawara S., et al. “Pityriasis rubra pilaris with preceding cytomegalovirus infection”. Dermatology 219 (2009): 350-352.
  24. Wang T., et al. “Pityriasis rubra pilaris (PRP) with preceding Epstein-Barr virus infection: a new type PRP with non-HIV virus infection?” Chinese Medical Journal 127 (2014): 2391.
  25. Erdem T., et al. “Pityriasis rubra pilaris in association with hepatitis A”. Saudi Medical Journal 27 (2006): 1421-1422.
  26. Ertam I., et al. “A case of juvenile pityriasis rubra pilaris: could varicella be an aetiological agent?” Clinical and Experimental Dermatology 34 (2009): e1012-e1013.
  27. Das JK., et al. “Pityriasis rubra pilaris with Koebner’s isomorphic phenomenon”. Indian Journal of Dermatology, Venereology and Leprology 76 (2010):194-196.
  28. Allison DS., et al. “Pityriasis rubra pilaris in children”. Journal of the American Academy of Dermatology 47 (2002): 386-389.
  29. Iredale HE and Meggitt SJ. “Photosensitive pityriasis rubra pilaris”. Clinical and Experimental Dermatology 31 (2006): 36-38.
  30. Evangelou G., et al. “Photoaggravated pityriasis rubra pilaris”. Photodermatology, Photoimmunology and Photomedicine 21 (2005): 272-274.
  31. Jack A., et al. “Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib”. Journal of the American Academy of Dermatology 69 (2013): e249-e250.
  32. Paz C., et al. “Sorafenib-induced eruption resembling pityriasis rubra pilaris”. Journal of the American Academy of Dermatology 65 (2011): 452-453.
  33. Plana A., et al. “Pityriasis rubra pilaris-like reaction induced by imatinib”. Clinical and Experimental Dermatology 38 (2013): 520-522.
  34. Stalling SS., et al. “Telaprevir-induced pityriasis rubra pilaris-like drug eruption”. Archives of Dermatological 148 (2012): 1215-1217.
  35. Cheung EJ., et al. “Sofosbuvir-induced erythrodermic pityriasis rubra pilaris-like drug eruption”. Journal of Drugs in Dermatology 14 (2015): 1161-1162.
  36. Yang FC., et al. “Pityriasis rubra pilaris exacerbation with topical use of imiquimod”. International Journal of Dermatology 47 (2008): 1076-1078.
  37. Atanaskova MN., et al. “Acantholytic pityriasis rubra pilaris”. Case Reports in Dermatological Medicine (2011): 412684.
  38. Go´mez-Moyano E., et al. “Pityriasis rubra pilaris with focal acantholytic dyskeratosis during treatment with imiquimod 5% cream”. Actas Dermo-Sifiliográficas 101 (2010): 898-900.
  39. Waldorf DS and Hambrick GW. “Vitamin A-responsive pityriasis rubra pilaris with myasthenia gravis”. Archives of Dermatology 92 (1965): 424-427.
  40. Gu¨l U., et al. “A case of pityriasis rubra pilaris associated with sacroileitis and autoimmune thyroiditis”. Journal of the European Academy of Dermatology and Venereology 22 (2008): 889-890.
  41. Orlandini V., et al. “Pityriasis rubra pilaris and hypothyroidism. Efficacy of thyroid hormone replacement therapy in skin recovery”. British Journal of Dermatology 156 (2007): 606-607.
  42. Franzotti AM., et al. “Pityriasis Rubra Pilar and hypothyroidism”. Anais Brasileiros de Dermatologia 89 (2014): 497-500.
  43. Randle HW and Winkelmann RK. “Pityriasis rubra pilaris and celiac sprue with malabsorption”. Cutis 25 (1980): 626-627.
  44. Hazini AR., et al. “Pityriasis rubra pilaris and vitiligo in Down’s syndrome”. Clinical and Experimental Dermatology 13 (1988): 334-335.
  45. Bar-Ilan E., et al. “Paraneoplastic pityriasis rubra pilaris: case report and literature review”. Clinical and Experimental Dermatology 42 (2017): 54-57.
  46. Sharma S., et al. “Pityriasis rubra pilaris as an initial presentation of hepatocellular carcinoma”. Dermatology 194 (1997): 166-167.
  47. Batinac T., et al. “Pityriasis rubra pilaris in association with laryngeal carcinoma”. Clinical and Experimental Dermatology 34 (2009): e917-e919.
  48. Kurzydlo A-M and Gillespie R. “Paraneoplastic pityriasis rubra pilaris in association with bronchogenic carcinoma”. The Australasian Journal of Dermatology 45 (2004): 130-132.
  49. Remedios IM., et al. “Paraneoplastic pityriasis rubra pilaris as the presenting manifestation of metastatic squamous cell carcinoma”. Journal of Drugs in Dermatology 13 (2014): 610-612.
  50. Garretson CB., et al. “Adenocarcinoma of the lung associated with pityriasis rubra pilaris [letter]”. Dermatology Online Journal 17 (2011):14.
  51. Batchelor RJ., et al. “Pityriasis rubra pilaris as the initial presentation of renal cell carcinoma? ” Clinical and Experimental Dermatology 30 (2005): 442-443.
  52. Reinhardt LA and Rosen T. “Pityriasis rubra pilaris as the initial manifestation of leukemia”. Cutis 31 (1983): 100-102.
  53. Sa´nchez-Regan˜a M., et al. “Pityriasis rubra pilaris as the initial manifestation of internal neoplasia”. Clinical and Experimental Dermatology 20 (1995): 436-438.
  54. Vitiello M., et al. “Pityriasis rubra pilaris: was it the first manifestation of colon cancer in a patient with pre-existing psoriasis?” Journal of the American Academy of Dermatology 68 (2013): e43-e44.
  55. Piamphongsant T and Akaraphant R. “Pityriasis rubra pilaris: a new proposed classification”. Clinical and Experimental Dermatology 19 (1994): 134-138.
Citation: Iqbal Bukhari., et al. “Pityriasis Rubra Pilaris in a 2-Year-Old Arabic Male; Case Report". EC Clinical and Medical Case Reports 3.4 (2020): 101-106.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to